Biofrontera AG
BFFTF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $510 | $2,561 | $2,224 | $2,024 |
| - Cash | $1,343 | $17,208 | $24,545 | $8,080 |
| + Debt | $6,090 | $1,346 | $0 | $0 |
| Enterprise Value | $5,257 | -$13,301 | -$22,321 | -$6,056 |
| Revenue | $34,071 | $28,674 | $24,100 | $18,849 |
| % Growth | 18.8% | 19% | 27.9% | – |
| Gross Profit | $16,627 | $13,489 | $11,358 | $9,783 |
| % Margin | 48.8% | 47% | 47.1% | 51.9% |
| EBITDA | -$18,453 | $934 | -$36,757 | -$7,492 |
| % Margin | -54.2% | 3.3% | -152.5% | -39.7% |
| Net Income | -$20,131 | -$640 | -$37,713 | -$10,987 |
| % Margin | -59.1% | -2.2% | -156.5% | -58.3% |
| EPS Diluted | -13.02 | -0.61 | -44.1 | -18.94 |
| % Growth | -2,034.4% | 98.6% | -132.8% | – |
| Operating Cash Flow | -$24,895 | -$16,199 | -$26,715 | -$12,369 |
| Capital Expenditures | -$5 | -$38 | -$11 | $0 |
| Free Cash Flow | -$24,900 | -$16,237 | -$26,726 | -$12,369 |